Skip to main content
SpringerLink
Log in

Papillary Thyroid Cancer

  • Chapter
A Case-Based Guide to Clinical Endocrinology

Part of the book series: Contemporary Endocrinology™ ((COE))

  • 1720 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 249.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hodgson NC, Button J, Solorzano CC. Thyroid cancer: Is the incidence still increasing? Ann Surg Oncol 2004;11:1093–1097.

    Article  PubMed  Google Scholar 

  2. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA. The spectrum of thyroid disease in the community: The Whickham Survey. Clin Endocrinol 1977;7:481–493.

    Article  CAS  Google Scholar 

  3. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Internal Med 1997;69:537–540.

    Google Scholar 

  4. Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med 2004;351(17):1764–1771.

    Article  PubMed  Google Scholar 

  5. Frates MC, Benson CB, Charboneau JW, Cibas ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB, Goellner JR, Hay ID, Hertzberg BS, Intenzo CM, Jeffrey RB, Langer JE, Larsen PR, Mandel SJ, Middleton WD, Reading CC, Sherman SI, Tessler FN; Society of Radiologists in Ultrasound. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound Consensus Conference Statement. Radiology 2005;237:794–800.

    Article  PubMed  Google Scholar 

  6. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics 2005. CA Cancer J Clin 2005;55:10–30.

    PubMed  Google Scholar 

  7. Sherman SI. Thyroid carcinoma. Lancet 2003;361(9356):501–511.

    Article  PubMed  Google Scholar 

  8. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI, Tuttle RM; The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Taskforce. Thyroid 2006;16(2):1–33.

    CAS  Google Scholar 

  9. Haugen BR. Initial treatment of differentiated thyroid carcinoma. Rev Endocr Metab Disord 2000;1:139–145.

    Article  PubMed  CAS  Google Scholar 

  10. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer 1998;83:2638–2648.

    Article  PubMed  CAS  Google Scholar 

  11. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414–424.

    PubMed  CAS  Google Scholar 

  12. Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary thyroid and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447–1463.

    Article  PubMed  CAS  Google Scholar 

  13. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992 Dec;112(6):1139–46.

    Google Scholar 

  14. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter. J Clin Endocrinol Metab 2004;89:3713–3720.

    Article  PubMed  CAS  Google Scholar 

  15. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up. Report of the impact of therapy in 576 patients. Am J Med 1981;70:511–518.

    Article  PubMed  CAS  Google Scholar 

  16. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy of papillary and follicular thyroid cancer. Am J Med 1994;97:418.

    Article  PubMed  CAS  Google Scholar 

  17. Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H. Small carcinomas of the thyroid. A long-term follow-up of 967 patients. Arch Surg 1996;131:187–191.

    PubMed  CAS  Google Scholar 

  18. Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL, Powell CC, van Heerden JA, Goellner JR. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades 1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002;26:879–885.

    Article  PubMed  Google Scholar 

  19. Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B, Cailleux AF, Lumbroso JD, Parmentier C, Schlumberger M. Microcarcinoma of the thyroid gland. The Gustave-Roussy Institute Experience. Cancer 1998;83:553–559.

    Article  PubMed  CAS  Google Scholar 

  20. Shattuck TM, Westra WH, Ladenson PW, Arnold A. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl J Med 2005;352:2406–2412.

    Article  PubMed  CAS  Google Scholar 

  21. Dragoiescu C, Hoekstra OS, Kuik DJ, Lips P, Plaizier MA, Rodrigus PT, Huijsmans DA, Ribot JG, Kuijpens J, Coebergh JW, Teule GJ. Feasibility of a randomized trial on adjuvant radio-iodine therapy in differentiated thyroid cancer. Clin Endocrinol 2003;58:451–455.

    Article  CAS  Google Scholar 

  22. Taylor T, Specker B, Robbins J, Sperling M, Ho M, Ain K, Bigos ST, Brierley J, Cooper D, Haugen B, Hay I, Hertzberg V, Klein I, Klein H, Ladenson P, Nishiyama R, Ross D, Sherman S, Maxon HR. Outcome after treatment of high risk papillary and non-Hurthle-cell follicular thyroid carcinoma. Ann Intern Med 1998;129:622–627.

    PubMed  CAS  Google Scholar 

  23. Mazzaferri EL. Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma. Thyroid 1997;7:265–271.

    PubMed  CAS  Google Scholar 

  24. Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G, Gerstein HC. A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 2004;89:3668–3676.

    Article  PubMed  CAS  Google Scholar 

  25. Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, Dondon MG, Abbas MT, Langlois C, Schlumberger M. Second primary malignancies in thyroid cancer patients. Br J Cancer 2003;89:1666–1673.

    Google Scholar 

  26. Bal CS, Kumar A, Pant GS. Radioiodine dose for Remnant ablation in differentiated thyroid carcinoma. A randomized clinical trial in 509 patients. J Clin Endocrinol Metab 2004;89:1666–1673.

    Article  PubMed  CAS  Google Scholar 

  27. Pacini F, Ladenson PW, Schlumberger M, Driedger A, Luster M, Kloos RT, Sherman S, Haugen B, Corone C, Molinaro E, Elisei R, Ceccarelli C, Pinchera A, Wahl RL, Leboulleux S, Ricard M, Yoo J, Busaidy NL, Delpassand E, Hanscheid H, Felbinger R, Lassmann M, Reiners C. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab. 2006 Mar;91(3):926–32.

    Google Scholar 

  28. McGiff NJ, Csako G, Gourgiotis L, Lori CG, Pucino F, Sarlis NJ. Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med 2002;34:554–556.

    Article  Google Scholar 

  29. Kamel N , Güllü S, Daĝci Ilgin S, Corapçioĝlu D, Tonyukuk Cesur V, Uysal AR, Başkal N, Erdoĝan G. Degree of thyrotropin suppression in differentiated thyroid cancer without recurrence or metastases. Thyroid. 1999 Dec;9(12):1245–8.

    Google Scholar 

  30. Cooper DS, Specker B, Ho M, Sperling M, Ladenson PW, Ross DS, Ain KB, Bigos ST, Brierley JD, Haugen BR, Klein I, Robbins J, Sherman SI, Taylor T, Maxon HR 3rd. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the Nation Thyroid Cancer Treatment Cooperative Registry. Thyroid 1998;8:737–744.

    Article  PubMed  CAS  Google Scholar 

  31. Wang ST, Liu RT, Chien WY, Tung SC, Lu YC, Chen HY, Lee CH, Wang PW. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1999;84:4549–4553.

    Article  PubMed  CAS  Google Scholar 

  32. Sherman SI, Angelos P, Lurie RH, Ball DW, Byrd D, Clark OH, Daniels GH, Dilawari RA, Ehya H, Farrar WB, Gagel RF, Kandeel F, Kloos RT, Kopp P, Lamonica DH, Loree TR, Lydiatt WM, McCaffrey J, Olson JA, Ridge JA, Shah JP, Sisson JC, Tuttle RM, Urist MM. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, http://www.nccn.org/professionals/physician_gls/PDF/thyroid.pdf v.2.2007.

    Google Scholar 

  33. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A. A consensus report of the role of serum thyroglobulin as a monitoring for low-risk patients with papillary thyroid cancer. J Clin Endocrinol Metab 2003;88:1433–1441.

    Article  PubMed  CAS  Google Scholar 

  34. Robins RJ, Chon JT, Fleisher M, Larson SM, Tuttle RM. Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? J Clin Endocrinol Metab 2002;87:3242–3247.

    Article  Google Scholar 

  35. Torlontano M, Attard M, Crocetti U, Tumino S, Bruno R, Costante G, D’Azzò G, Meringolo D, Ferretti E, Sacco R, Arturi F, Filetti S. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph nodes metastases. J Clin Endocrinol Metab 2004;89:3402–3407.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Uniformed Services University of the Health Sciences, Bethesda, MD

    Nicole Ehrhardt (Instructor of Medicine)

  2. National Capitol Consortium Endocrinology Fellowship, Walter Reed Army Medical Center, Washington, DC

    Victor Bernet (Director)

Authors
  1. Nicole Ehrhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Victor Bernet
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Mount Sinai School of Medicine, The Mount Sinai Hospital and the James J. Peters VA Medical Center, New York, NY

    Terry F. Davies

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press,Totowa, NJ

About this chapter

Cite this chapter

Ehrhardt, N., Bernet, V. (2008). Papillary Thyroid Cancer. In: Davies, T.F. (eds) A Case-Based Guide to Clinical Endocrinology. Contemporary Endocrinology™. Humana Press. https://doi.org/10.1007/978-1-60327-103-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-103-5_11

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-815-7

  • Online ISBN: 978-1-60327-103-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation